This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
NIH Overzicht aandelen
Operates as a digital commerce enabler in the Middle East and Africa.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 0/6 |
Network International Holdings plc Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | UK£4.62 |
| 52 Week Hoogtepunt | UK£4.73 |
| 52 Week Laag | UK£4.30 |
| Bèta | 0.88 |
| 11 maand verandering | 1.41% |
| 3 maanden verandering | -0.22% |
| 1 Jaar Verandering | 2.17% |
| 33 jaar verandering | 9.95% |
| 5 jaar verandering | -25.76% |
| Verandering sinds IPO | -21.23% |
Recent nieuws en updates
Recent updates
Rendement voor aandeelhouders
| NIH | DE Diversified Financial | DE Markt | |
|---|---|---|---|
| 7D | 0.4% | 1.2% | 1.1% |
| 1Y | 2.2% | 55.3% | 18.9% |
Rendement versus industrie: NIH underperformed the German Diversified Financial industry which returned 16.2% over the past year.
Rendement versus markt: NIH underperformed the German Market which returned 5.7% over the past year.
Prijsvolatiliteit
| NIH volatility | |
|---|---|
| NIH Average Weekly Movement | 1.3% |
| Diversified Financial Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stabiele aandelenkoers: NIH has not had significant price volatility in the past 3 months.
Volatiliteit in de loop van de tijd: NIH's weekly volatility (1%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1994 | 2,133 | Nandan Mer | www.network.ae |
Network International Holdings plc Samenvatting
| NIH fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €2.53b |
| Inkomsten(TTM) | €59.00m |
| Inkomsten(TTM) | €440.19m |
42.9x
Koers/Winstverhouding5.7x
P/S-verhoudingIs NIH overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| NIH resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$490.13m |
| Kosten van inkomsten | US$144.11m |
| Brutowinst | US$346.03m |
| Overige uitgaven | US$280.34m |
| Inkomsten | US$65.69m |
Laatst gerapporteerde inkomsten
Dec 31, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.12 |
| Brutomarge | 70.60% |
| Nettowinstmarge | 13.40% |
| Schuld/Eigen Vermogen Verhouding | 68.4% |
Hoe presteerde NIH op de lange termijn?
Bekijk historische prestaties en vergelijking